Archidply Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 8:09 pm

Competitors of Archidply Industries Ltd

All Competitor Stocks of Archidply Industries Ltd

Quarterly Result

Last Updated: August 2, 2025, 12:10 am

Below is a detailed analysis of the quarterly data for Archidply Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 119.33 Cr.. The value appears to be declining and may need further review. It has decreased from 128.33 Cr. (Mar 2025) to 119.33 Cr., marking a decrease of 9.00 Cr..
• For Expenses, as of Jun 2025, the value is 112.25 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 121.05 Cr. (Mar 2025) to 112.25 Cr., marking a decrease of 8.80 Cr..
• For Operating Profit, as of Jun 2025, the value is 7.08 Cr.. The value appears to be declining and may need further review. It has decreased from 7.28 Cr. (Mar 2025) to 7.08 Cr., marking a decrease of 0.20 Cr..
• For OPM %, as of Jun 2025, the value is 5.93%. The value appears strong and on an upward trend. It has increased from 5.67% (Mar 2025) to 5.93%, marking an increase of 0.26%.
• For Other Income, as of Jun 2025, the value is 0.23 Cr.. The value appears to be declining and may need further review. It has decreased from 0.36 Cr. (Mar 2025) to 0.23 Cr., marking a decrease of 0.13 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.32 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 0.32 Cr..
• For Depreciation, as of Jun 2025, the value is 1.06 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.34 Cr. (Mar 2025) to 1.06 Cr., marking a decrease of 0.28 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.25 Cr.. The value appears strong and on an upward trend. It has increased from 3.98 Cr. (Mar 2025) to 4.25 Cr., marking an increase of 0.27 Cr..
• For Tax %, as of Jun 2025, the value is 29.18%. The value appears to be increasing, which may not be favorable. It has increased from 27.89% (Mar 2025) to 29.18%, marking an increase of 1.29%.
• For Net Profit, as of Jun 2025, the value is 3.01 Cr.. The value appears strong and on an upward trend. It has increased from 2.86 Cr. (Mar 2025) to 3.01 Cr., marking an increase of 0.15 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.52. The value appears strong and on an upward trend. It has increased from 1.44 (Mar 2025) to 1.52, marking an increase of 0.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:23 pm

Growth

Last Updated: September 4, 2025, 11:30 pm

Balance Sheet

Last Updated: August 11, 2025, 1:38 pm

Below is a detailed analysis of the balance sheet data for Archidply Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Reserves, as of Mar 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Mar 2024) to 99.00 Cr., marking an increase of 7.00 Cr..
• For Borrowings, as of Mar 2025, the value is 85.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 72.00 Cr. (Mar 2024) to 85.00 Cr., marking an increase of 13.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 69.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 58.00 Cr. (Mar 2024) to 69.00 Cr., marking an increase of 11.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 274.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 242.00 Cr. (Mar 2024) to 274.00 Cr., marking an increase of 32.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Mar 2024) to 41.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2024) to 67.00 Cr., marking an increase of 25.00 Cr..
• For Other Assets, as of Mar 2025, the value is 165.00 Cr.. The value appears strong and on an upward trend. It has increased from 158.00 Cr. (Mar 2024) to 165.00 Cr., marking an increase of 7.00 Cr..
• For Total Assets, as of Mar 2025, the value is 274.00 Cr.. The value appears strong and on an upward trend. It has increased from 242.00 Cr. (Mar 2024) to 274.00 Cr., marking an increase of 32.00 Cr..

Notably, the Reserves (99.00 Cr.) exceed the Borrowings (85.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Archidply Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -3.70. This value is below the healthy minimum of 5. It has decreased from 3.57 (Mar 24) to -3.70, marking a decrease of 7.27.
• For Diluted EPS (Rs.), as of Mar 25, the value is -3.70. This value is below the healthy minimum of 5. It has decreased from 3.57 (Mar 24) to -3.70, marking a decrease of 7.27.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.04. This value is within the healthy range. It has decreased from 5.82 (Mar 24) to 3.04, marking a decrease of 2.78.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.31. It has decreased from 56.14 (Mar 24) to 52.31, marking a decrease of 3.83.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.31. It has decreased from 56.14 (Mar 24) to 52.31, marking a decrease of 3.83.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 279.85. It has increased from 219.32 (Mar 24) to 279.85, marking an increase of 60.53.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 11.79. This value is within the healthy range. It has decreased from 12.20 (Mar 24) to 11.79, marking a decrease of 0.41.
• For PBIT / Share (Rs.), as of Mar 25, the value is 5.05. This value is within the healthy range. It has decreased from 9.95 (Mar 24) to 5.05, marking a decrease of 4.90.
• For PBT / Share (Rs.), as of Mar 25, the value is -3.88. This value is below the healthy minimum of 0. It has decreased from 6.20 (Mar 24) to -3.88, marking a decrease of 10.08.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -3.70. This value is below the healthy minimum of 2. It has decreased from 3.57 (Mar 24) to -3.70, marking a decrease of 7.27.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -3.70. This value is below the healthy minimum of 2. It has decreased from 3.57 (Mar 24) to -3.70, marking a decrease of 7.27.
• For PBDIT Margin (%), as of Mar 25, the value is 4.21. This value is below the healthy minimum of 10. It has decreased from 5.56 (Mar 24) to 4.21, marking a decrease of 1.35.
• For PBIT Margin (%), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 10. It has decreased from 4.53 (Mar 24) to 1.80, marking a decrease of 2.73.
• For PBT Margin (%), as of Mar 25, the value is -1.38. This value is below the healthy minimum of 10. It has decreased from 2.82 (Mar 24) to -1.38, marking a decrease of 4.20.
• For Net Profit Margin (%), as of Mar 25, the value is -1.32. This value is below the healthy minimum of 5. It has decreased from 1.62 (Mar 24) to -1.32, marking a decrease of 2.94.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -1.32. This value is below the healthy minimum of 8. It has decreased from 1.62 (Mar 24) to -1.32, marking a decrease of 2.94.
• For Return on Networth / Equity (%), as of Mar 25, the value is -7.08. This value is below the healthy minimum of 15. It has decreased from 6.36 (Mar 24) to -7.08, marking a decrease of 13.44.
• For Return on Capital Employeed (%), as of Mar 25, the value is 5.75. This value is below the healthy minimum of 10. It has decreased from 10.34 (Mar 24) to 5.75, marking a decrease of 4.59.
• For Return On Assets (%), as of Mar 25, the value is -1.87. This value is below the healthy minimum of 5. It has decreased from 2.17 (Mar 24) to -1.87, marking a decrease of 4.04.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.64 (Mar 24) to 0.58, marking a decrease of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.85. This value exceeds the healthy maximum of 1. It has increased from 1.31 (Mar 24) to 1.85, marking an increase of 0.54.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.55. It has increased from 1.52 (Mar 24) to 1.55, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 1.5. It has decreased from 1.21 (Mar 24) to 1.06, marking a decrease of 0.15.
• For Quick Ratio (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.81 (Mar 24) to 0.69, marking a decrease of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.28. This value exceeds the healthy maximum of 8. It has increased from 2.45 (Mar 24) to 8.28, marking an increase of 5.83.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 3. It has decreased from 3.25 (Mar 24) to 1.32, marking a decrease of 1.93.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 3. It has decreased from 1.95 (Mar 24) to 0.58, marking a decrease of 1.37.
• For Enterprise Value (Cr.), as of Mar 25, the value is 360.29. It has increased from 308.35 (Mar 24) to 360.29, marking an increase of 51.94.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 24) to 0.64, marking a decrease of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 15.38. This value exceeds the healthy maximum of 15. It has increased from 12.72 (Mar 24) to 15.38, marking an increase of 2.66.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.37 (Mar 24) to 0.30, marking a decrease of 0.07.
• For Price / BV (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has increased from 1.47 (Mar 24) to 1.62, marking an increase of 0.15.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.37 (Mar 24) to 0.30, marking a decrease of 0.07.
• For EarningsYield, as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to -0.04, marking a decrease of 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness